JSM 2011 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.


645	Thu, 8/4/2011, 10:30 AM - 12:20 PM	CC-A201
Improving Designs and Analysis Methodologies in Clinical Trials — Topic Contributed Papers
International Chinese Statistical Association
Organizer(s): Xiaohong Huang, sanofi-aventis
Chair(s): Zhenming Shun, sanofi-aventis
10:35 AM	Classification of Endpoints and Strong Control of Type I Error Rates for Both Primary and Secondary Endpoints in Clinical Trials — Abdul J. Sankoh, Vertex Pharmaceuticals ; Haihong Li, Vertex Pharmaceuticals
10:55 AM	Statistical Considerations for the Sequential Parallel Design — Roy N. Tamura, Eli Lilly and Company
11:15 AM	Can the Line Between Primary and Secondary Endpoints Be Blurred? A Method to Adaptively Test Multiple Endpoints with Emerging Data — Yang Song, Merck & Co., Inc.
11:35 AM	Design and Analysis of Crossover Trials for Absorbing Binary Endpoints — Martha Nason, National Institute of Allergy and Infectious Diseases ; Dean Follmann, National Institute of Allergy and Infectious Diseases
11:55 AM	Floor Discussion

2011 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.